![Charles C. Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles C. Clark
Career history of Charles C. Clark
Former positions of Charles C. Clark
Companies | Position | Start | End |
---|---|---|---|
Caremark Rx, Inc.
![]() Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Corporate Officer/Principal | - | 2007-03-22 |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Director/Board Member | - | - |
Statistics
International
United States | 3 |
Operational
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoral
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Caremark Rx, Inc.
![]() Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Health Services |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
- Stock Market
- Insiders
- Charles C. Clark
- Experience